{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:31:43Z","timestamp":1781818303312,"version":"3.54.5"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hyperlipidemia is known to impair endothelial function. We have recently shown that hyperlipidemia also blunts native post-ischemic capillary enlargement that is important for efficient skeletal muscle recovery from ischemia as it supports the recovery of arterial driving pressure and through intussusception increases capillary density. The correction of capillary reactivity under hyperlipidemia could, therefore, improve post-ischemic skeletal muscle recovery. This study tested the ability of adenoviral (Ad) vascular endothelial growth factor (VEGF) gene therapy to rescue capillary enlargement and improve post-ischemic muscle repair in hyperlipidemic mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>AdVEGF or AdLacZ-control vector were delivered into the calf muscles of aged, hyperlipidemic LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>ApoB<jats:sup>100\/100<\/jats:sup> mice (n = 58) after induction of acute ischemia. The effects of AdVEGF on capillary phenotype, tissue edema, restoration of blood flow parameters, microvascular hemoglobin oxygenation and tissue damage\/regeneration were evaluated using immunohistological analyses, magnetic resonance imaging, contrast-enhanced ultrasound imaging, photoacoustic imaging and histological analyses, respectively, up to 29 days after induced ischemia and gene transfer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>It was found that AdVEGF gene therapy was able to promote capillary enlargement (P &amp;lt; 0.05) that led to recovery of arterial driving pressure in ischemic LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>ApoB<jats:sup>100\/100<\/jats:sup> muscles. However, capillary enlargement induced by AdVEGF in the hyperlipidemic mice was delayed, had a long-lasting effect (P &amp;lt; 0.05) and did not promote intussusception. Instead, side-effects of VEGF-induced capillary enlargement, i.e., tissue edema (P &amp;lt; 0.01) and subsequently delayed blood flow recovery (P &amp;lt; 0.05), aggravated ischemic tissue damage (P &amp;lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Hyperlipidemia or old age did not seem to impair AdVEGF-induced capillary enlargement. However, regarding the side-effects of capillary enlargement, therapies trying to promote post-ischemic skeletal muscle recovery through angiogenesis should consider not only capillary size or density but also timing and dynamics of the capillary changes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbioe.2025.1512962","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:24:54Z","timestamp":1748323494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Sustained capillary enlargement induced by angiogenic gene therapy does not support post-ischemic muscle recovery of hyperlipidemic mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Galina","family":"Wirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Juusola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihay","family":"Laham-Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Korpisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/circresaha.121.318266","article-title":"New directions in therapeutic angiogenesis and arteriogenesis in peripheral arterial disease","volume":"128","author":"Annex","year":"2021","journal-title":"Circ. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvq105","article-title":"Vascular endothelial growth factors and vascular permeability","volume":"87","author":"Bates","year":"2010","journal-title":"Cardiovasc Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"115108","DOI":"10.1016\/j.bcp.2022.115108","article-title":"Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: novel opportunities for primary prevention","volume":"202","author":"Benincasa","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"III27","DOI":"10.1161\/01.cir.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1242\/dmm.010413","article-title":"Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success","volume":"6","author":"Dragneva","year":"2013","journal-title":"DMM Dis. Model. Mech."},{"key":"B7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/s0008-6363(00)00282-0","article-title":"Unorthodox angiogenesis in skeletal muscle","volume":"49","author":"Egginton","year":"2001","journal-title":"Cardiovasc Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/01.cir.102.5.565","article-title":"Adenovirus-mediated VEGF121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia","volume":"102","author":"Gowdak","year":"2000","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1549-8719.2009.00015.x","article-title":"Microvascular responses to cardiovascular risk factors","volume":"17","author":"Granger","year":"2010","journal-title":"Microcirculation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/circresaha.109.200386","article-title":"Human studies of angiogenic gene therapy","volume":"105","author":"Gupta","year":"2009","journal-title":"Circ. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/circresaha.107.154401","article-title":"Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia","volume":"101","author":"Heinonen","year":"2007","journal-title":"Circ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cells12091293","article-title":"Endothelial function in dyslipidemia: roles of LDL-cholesterol, HDL-cholesterol and triglycerides","volume":"12","author":"Higashi","year":"2023","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jacbts.2017.07.012","article-title":"Therapeutic angiogenesis for peripheral artery disease: lessons learned in translational science","volume":"2","author":"Iyer","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1054576","DOI":"10.3389\/fcvm.2022.1054576","article-title":"Endothelial cell dysfunction: implications for the pathogenesis of peripheral artery disease","volume":"9","author":"Kavurma","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/hum.2006.100","article-title":"Adenovirus-mediated gene transfer of human vascular endothelial growth factor-D induces transient angiogenic effects in mouse hind limb muscle","volume":"18","author":"Kholov\u00e1","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/eurheartj\/ehq433","article-title":"Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy","volume":"32","author":"Korpisalo","year":"2011","journal-title":"Eur. Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/circresaha.108.182287","article-title":"Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels","volume":"103","author":"Korpisalo","year":"","journal-title":"Circ. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/cvr\/cvn195","article-title":"Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs","volume":"80","author":"Korpisalo","year":"","journal-title":"Cardiovasc Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1161\/atvbaha.120.315028","article-title":"Systematic interrogation of angiogenesis in the ischemic mouse hind limb: vulnerabilities and quality assurance","volume":"40","author":"Lee","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/gt.2009.30","article-title":"Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia","volume":"16","author":"Olea","year":"2009","journal-title":"Gene Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e240009","DOI":"10.1530\/vb-24-0009","article-title":"Therapeutic angiogenesis for patients with chronic limb-threatening ischemia: promising or hoax?","volume":"6","author":"Peeters","year":"2024","journal-title":"Vasc. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcmg.2007.10.009","article-title":"High-resolution ultrasound perfusion imaging of therapeutic angiogenesis","volume":"1","author":"Rissanen","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1161\/circulationaha.105.543124","article-title":"Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis","volume":"112","author":"Rissanen","year":"2005","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.mt.6300175","article-title":"Current status of cardiovascular gene therapy","volume":"15","author":"Rissanen","year":"2007","journal-title":"Mol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1748-1716.2011.02321.x","article-title":"Intussusceptive angiogenesis: pillars against the blood flow","volume":"202","author":"Styp-Rekowska","year":"2011","journal-title":"Acta Physiol. (Oxf)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"ehad562","DOI":"10.1093\/eurheartj\/ehad562","article-title":"Critical limb-threatening ischemia and microvascular transformation: clinical implications","volume":"27","author":"Tarvainen","year":"2023","journal-title":"Eur. Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1172\/jci4164","article-title":"Lipoprotein clearance mechanisms in LDL receptor-deficient \u201capo-B48- only\u201d and \u201capo-B100-only\u201d mice","volume":"102","author":"V\u00e9niant","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/cells12162060","article-title":"Capillary dynamics regulate post-ischemic muscle damage and regeneration in experimental hindlimb ischemia","volume":"12","author":"Wirth","year":"2023","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/eurheartj\/ehw547","article-title":"Angiogenic gene therapy in cardiovascular diseases: dream or vision?","volume":"38","author":"Yl\u00e4-Herttuala","year":"2017","journal-title":"Eur. Heart J."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2025.1512962\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:24:54Z","timestamp":1748323494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2025.1512962\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":31,"alternative-id":["10.3389\/fbioe.2025.1512962"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2025.1512962","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"article-number":"1512962"}}